Sung et. al. identify genetic, molecular and clinical risk factors for immune-related adverse events in multicancer cohorts of patients treated with checkpoint inhibitors and develop predictive models that they validate in an independent cohort.
- Changhwan Sung
- Jinhyeon An
- Sook Ryun Park
